Iran Rashedi

1.2k total citations
18 papers, 996 citations indexed

About

Iran Rashedi is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Iran Rashedi has authored 18 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Iran Rashedi's work include Mesenchymal stem cell research (6 papers), CAR-T cell therapy research (3 papers) and Immune Response and Inflammation (3 papers). Iran Rashedi is often cited by papers focused on Mesenchymal stem cell research (6 papers), CAR-T cell therapy research (3 papers) and Immune Response and Inflammation (3 papers). Iran Rashedi collaborates with scholars based in Canada, Iran and Poland. Iran Rashedi's co-authors include Armand Keating, Marek Łoś, Saeid Ghavami, Soumya Panigrahi, Claus Kerkhoff, Sebastian Wesselborg, Brian M. Dattilo, Walter Chazin, Mehdi Eshraghi and Mohammad Hashemi and has published in prestigious journals such as Blood, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Iran Rashedi

18 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iran Rashedi Canada 11 515 225 203 163 134 18 996
Stanisław Szala Poland 20 842 1.6× 345 1.5× 113 0.6× 313 1.9× 106 0.8× 78 1.4k
Christoph Peter Germany 20 957 1.9× 392 1.7× 190 0.9× 87 0.5× 199 1.5× 50 1.6k
Qingshan Yang China 15 562 1.1× 100 0.4× 147 0.7× 126 0.8× 37 0.3× 45 962
Youliang Wang China 20 696 1.4× 278 1.2× 103 0.5× 232 1.4× 107 0.8× 44 1.5k
Virginie Millet France 15 481 0.9× 137 0.6× 104 0.5× 99 0.6× 91 0.7× 21 958
Nam‐ho Huh Japan 23 1.2k 2.3× 212 0.9× 53 0.3× 218 1.3× 118 0.9× 65 1.8k
Ke Jin China 21 626 1.2× 351 1.6× 37 0.2× 145 0.9× 84 0.6× 66 1.4k
Zhenzhen Zhan China 17 658 1.3× 507 2.3× 61 0.3× 118 0.7× 109 0.8× 41 1.3k
Gaurav Mehta United States 21 526 1.0× 361 1.6× 35 0.2× 263 1.6× 64 0.5× 36 1.3k

Countries citing papers authored by Iran Rashedi

Since Specialization
Citations

This map shows the geographic impact of Iran Rashedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iran Rashedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iran Rashedi more than expected).

Fields of papers citing papers by Iran Rashedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iran Rashedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iran Rashedi. The network helps show where Iran Rashedi may publish in the future.

Co-authorship network of co-authors of Iran Rashedi

This figure shows the co-authorship network connecting the top 25 collaborators of Iran Rashedi. A scholar is included among the top collaborators of Iran Rashedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iran Rashedi. Iran Rashedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rashedi, Iran, Kathryn Mangoff, Gail Klein, et al.. (2024). Intensity of survivin expression linked to features of aggressive relapsed/refractory diffuse large B-cell lymphoma. Leukemia & lymphoma. 66(1). 84–94. 1 indexed citations
2.
3.
Rashedi, Iran, Kathryn Mangoff, Douglas A. Stewart, et al.. (2023). PD‐L1 expression predicts efficacy in the phase II SPiReL trial with MVP‐S, pembrolizumab, and low‐dose CPA in R/R DLBCL. European Journal Of Haematology. 111(2). 191–200. 7 indexed citations
4.
Berinstein, Neil L., Isabelle Bence‐Bruckler, Pierre Laneuville, et al.. (2020). Clinical Effectiveness of Combination Immunotherapy DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study. Blood. 136(Supplement 1). 16–16. 4 indexed citations
5.
Kosaka, Yoko, et al.. (2019). Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells. Stem Cells and Development. 28(14). 933–943. 38 indexed citations
6.
Yoon, Nara, Iran Rashedi, Víctor Dayan, et al.. (2018). Human mesenchymal stromal cells do not promote recurrence of soft tissue sarcomas in mouse xenografts after radiation and surgery. Cytotherapy. 20(8). 1001–1012. 2 indexed citations
7.
Abdi, Jahangir, Iran Rashedi, & Armand Keating. (2018). Concise Review: TLR Pathway-miRNA Interplay in Mesenchymal Stromal Cells: Regulatory Roles and Therapeutic Directions. Stem Cells. 36(11). 1655–1662. 34 indexed citations
8.
Rashedi, Iran, Nilesh P. Talele, Xinghua Wang, et al.. (2017). Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells. PLoS ONE. 12(10). e0187348–e0187348. 56 indexed citations
9.
Saleh, Mohammad H., Iran Rashedi, & Armand Keating. (2017). Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide. Frontiers in Immunology. 8. 1087–1087. 66 indexed citations
10.
Rashedi, Iran, A. Gómez-Aristizábal, Xinghua Wang, Sowmya Viswanathan, & Armand Keating. (2016). TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling. Stem Cells. 35(1). 265–275. 112 indexed citations
11.
Farahani, Ensieh, et al.. (2014). Cell adhesion molecules and their relation to (cancer) cell stemness. Carcinogenesis. 35(4). 747–759. 148 indexed citations
12.
Łoś, Marek, Soumya Panigrahi, Iran Rashedi, et al.. (2009). Apoptin, a tumor-selective killer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793(8). 1335–1342. 96 indexed citations
13.
Hombach‐Klonisch, Sabine, Soumya Panigrahi, Iran Rashedi, et al.. (2008). Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applications. Journal of Molecular Medicine. 86(12). 1301–1314. 101 indexed citations
14.
Ghavami, Saeid, Iran Rashedi, Brian M. Dattilo, et al.. (2008). S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. Journal of Leukocyte Biology. 83(6). 1484–1492. 262 indexed citations
15.
Rashedi, Iran, Soumya Panigrahi, Peyman Ezzati, Saeid Ghavami, & Marek Łoś. (2007). Autoimmunity and Apoptosis - Therapeutic Implications. Current Medicinal Chemistry. 14(29). 3139–3151. 42 indexed citations
16.
Krzemieniecki, Krzysztof, et al.. (2006). Targeting of solid tumors and blood malignancies by antibody-based therapies — EGFR-pathway as an example. Open Life Sciences. 1(2). 167–182. 13 indexed citations
17.
Kroczak, Tadeusz, Jarosław Baran, J Pryjma, et al.. (2006). The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation. Expert Opinion on Therapeutic Targets. 10(2). 289–302. 9 indexed citations
18.
Houshmand, Massoud, et al.. (2003). Lack of Association between Leber’s Hereditary Optic Neuropathy Primary Point Mutations and Multiple Sclerosis in Iran. European Neurology. 51(2). 68–71. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanisław Szala Breakdown of academic impact, for papers by Christoph Peter Breakdown of academic impact, for papers by Qingshan Yang Breakdown of academic impact, for papers by Youliang Wang Breakdown of academic impact, for papers by Virginie Millet Breakdown of academic impact, for papers by Nam‐ho Huh Breakdown of academic impact, for papers by Ke Jin Breakdown of academic impact, for papers by Zhenzhen Zhan Breakdown of academic impact, for papers by Gaurav Mehta
Rankless by CCL
2026